HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
499.21
+2.36 (0.47%)
At close: Feb 3, 2026, 4:00 PM EST
493.96
-5.25 (-1.05%)
After-hours: Feb 3, 2026, 7:57 PM EST
HCA Healthcare Stock Forecast
Stock Price Forecast
The 18 analysts that cover HCA Healthcare stock have a consensus rating of "Buy" and an average price target of $507.44, which forecasts a 1.65% increase in the stock price over the next year. The lowest target is $370 and the highest is $598.
Price Target: $507.44 (+1.65%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 6 | 5 | 5 | 6 | 6 |
| Buy | 6 | 7 | 7 | 7 | 6 | 6 |
| Hold | 9 | 9 | 9 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 22 | 21 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $452 → $481 | Hold | Maintains | $452 → $481 | -3.65% | Jan 30, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $535 → $590 | Strong Buy | Maintains | $535 → $590 | +18.19% | Jan 28, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $500 → $540 | Buy | Maintains | $500 → $540 | +8.17% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $525 → $555 | Buy | Maintains | $525 → $555 | +11.18% | Jan 28, 2026 |
| UBS | UBS | Strong Buy Maintains $525 → $598 | Strong Buy | Maintains | $525 → $598 | +19.79% | Jan 28, 2026 |
Financial Forecast
Revenue This Year
79.87B
from 75.60B
Increased by 5.65%
Revenue Next Year
83.98B
from 79.87B
Increased by 5.14%
EPS This Year
29.87
from 28.33
Increased by 5.47%
EPS Next Year
33.07
from 29.87
Increased by 10.70%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 84.6B | 89.2B | |||
| Avg | 79.9B | 84.0B | |||
| Low | 75.5B | 80.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.9% | 11.7% | |||
| Avg | 5.7% | 5.1% | |||
| Low | -0.2% | 0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 32.99 | 36.05 | |||
| Avg | 29.87 | 33.07 | |||
| Low | 26.71 | 29.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 16.5% | 20.7% | |||
| Avg | 5.5% | 10.7% | |||
| Low | -5.7% | -0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.